391 related articles for article (PubMed ID: 23682717)
1. Molecular modeling of vasopressin receptor and in silico screening of V1b receptor antagonists.
Hagiwara Y; Ohno K; Kamohara M; Takasaki J; Watanabe T; Fukunishi Y; Nakamura H; Orita M
Expert Opin Drug Discov; 2013 Aug; 8(8):951-64. PubMed ID: 23682717
[TBL] [Abstract][Full Text] [Related]
2. X-ray structure breakthroughs in the GPCR transmembrane region.
Topiol S; Sabio M
Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
[TBL] [Abstract][Full Text] [Related]
3. The use of GPCR structures in drug design.
Congreve M; Langmead C; Marshall FH
Adv Pharmacol; 2011; 62():1-36. PubMed ID: 21907905
[TBL] [Abstract][Full Text] [Related]
4. Fragment-based lead discovery on G-protein-coupled receptors.
Visegrády A; Keserű GM
Expert Opin Drug Discov; 2013 Jul; 8(7):811-20. PubMed ID: 23621346
[TBL] [Abstract][Full Text] [Related]
5. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.
Bhunia SS; Saxena AK
Curr Top Med Chem; 2021; 21(4):269-294. PubMed ID: 32901584
[TBL] [Abstract][Full Text] [Related]
6. PREDICT modeling and in-silico screening for G-protein coupled receptors.
Shacham S; Marantz Y; Bar-Haim S; Kalid O; Warshaviak D; Avisar N; Inbal B; Heifetz A; Fichman M; Topf M; Naor Z; Noiman S; Becker OM
Proteins; 2004 Oct; 57(1):51-86. PubMed ID: 15326594
[TBL] [Abstract][Full Text] [Related]
7. Structure-based and fragment-based GPCR drug discovery.
Andrews SP; Brown GA; Christopher JA
ChemMedChem; 2014 Feb; 9(2):256-75. PubMed ID: 24353016
[TBL] [Abstract][Full Text] [Related]
8. Modeling G protein-coupled receptors and their interactions with ligands.
Costanzi S
Curr Opin Struct Biol; 2013 Apr; 23(2):185-90. PubMed ID: 23415855
[TBL] [Abstract][Full Text] [Related]
9. In silico identification of novel G protein coupled receptors.
Davies MN; Flower DR
Methods Mol Biol; 2009; 528():25-36. PubMed ID: 19153682
[TBL] [Abstract][Full Text] [Related]
10. Homology modeling of G-protein-coupled receptors with X-ray structures on the rise.
Yarnitzky T; Levit A; Niv MY
Curr Opin Drug Discov Devel; 2010 May; 13(3):317-25. PubMed ID: 20443165
[TBL] [Abstract][Full Text] [Related]
11. Docking and Virtual Screening Strategies for GPCR Drug Discovery.
Beuming T; Lenselink B; Pala D; McRobb F; Repasky M; Sherman W
Methods Mol Biol; 2015; 1335():251-76. PubMed ID: 26260606
[TBL] [Abstract][Full Text] [Related]
12. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
[TBL] [Abstract][Full Text] [Related]
13. Modeling the 3D structure of GPCRs: advances and application to drug discovery.
Becker OM; Shacham S; Marantz Y; Noiman S
Curr Opin Drug Discov Devel; 2003 May; 6(3):353-61. PubMed ID: 12833668
[TBL] [Abstract][Full Text] [Related]
14. The 7 TM G-protein-coupled receptor target family.
Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
[TBL] [Abstract][Full Text] [Related]
15. Novel approaches for targeting the adenosine A2A receptor.
Yuan G; Gedeon NG; Jankins TC; Jones GB
Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
[TBL] [Abstract][Full Text] [Related]
16. Selection of in silico drug screening results for G-protein-coupled receptors by using universal active probes.
Wada M; Kanamori E; Nakamura H; Fukunishi Y
J Chem Inf Model; 2011 Sep; 51(9):2398-407. PubMed ID: 21848279
[TBL] [Abstract][Full Text] [Related]
17. The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
Filizola M; Weinstein H
Curr Opin Drug Discov Devel; 2005 Sep; 8(5):577-84. PubMed ID: 16159019
[TBL] [Abstract][Full Text] [Related]
18. From purified GPCRs to drug discovery: the promise of protein-based methodologies.
Alkhalfioui F; Magnin T; Wagner R
Curr Opin Pharmacol; 2009 Oct; 9(5):629-35. PubMed ID: 19443270
[TBL] [Abstract][Full Text] [Related]
19. Current assessment of docking into GPCR crystal structures and homology models: successes, challenges, and guidelines.
Beuming T; Sherman W
J Chem Inf Model; 2012 Dec; 52(12):3263-77. PubMed ID: 23121495
[TBL] [Abstract][Full Text] [Related]
20. The use of G-protein coupled receptor models in lead optimization.
Tautermann CS
Future Med Chem; 2011 Apr; 3(6):709-21. PubMed ID: 21554077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
